Introduction Avelumab
MSB0010718C is an investigational fully human IgG1 monoclonal antibody that binds to the programmed deathligand 1 PDL1 protein and competitively block interaction with programmed death1 PD1 receptors thereby enables the activation of Tcells and the adaptive immune system image 1
Embed this Presentation
Available Downloads
Download Notice
Download Presentation The PPT/PDF document "Introduction Avelumab" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.